Literature DB >> 16943199

Effect of DNA modifications on DNA processing by HIV-1 integrase and inhibitor binding: role of DNA backbone flexibility and an open catalytic site.

Allison A Johnson1, Jane M Sayer, Haruhiko Yagi, Sachindra S Patil, Françoise Debart, Martin A Maier, David R Corey, Jean-Jacques Vasseur, Terrence R Burke, Victor E Marquez, Donald M Jerina, Yves Pommier.   

Abstract

Integration of the viral cDNA into host chromosomes is required for viral replication. Human immunodeficiency virus integrase catalyzes two sequential reactions, 3'-processing (3'-P) and strand transfer (ST). The first integrase inhibitors are undergoing clinical trial, but interactions of inhibitors with integrase and DNA are not well understood in the absence of a co-crystal structure. To increase our understanding of integrase interactions with DNA, we examined integrase catalysis with oligonucleotides containing DNA backbone, base, and groove modifications placed at unique positions surrounding the 3'-processing site. 3'-Processing was blocked with substrates containing constrained sugars and alpha-anomeric residues, suggesting that integrase requires flexibility of the phosphodiester backbone at the 3'-P site. Of several benzo[a]pyrene 7,8-diol 9,10-epoxide (BaP DE) adducts tested, only the adduct in the minor groove at the 3'-P site inhibited 3'-P, suggesting the importance of the minor groove contacts for 3'-P. ST occurred in the presence of bulky BaP DE DNA adducts attached to the end of the viral DNA suggesting opening of the active site for ST. Position-specific effects of these BaP DE DNA adducts were found for inhibition of integrase by diketo acids. Together, these results demonstrate the importance of DNA structure and specific contacts with the viral DNA processing site for inhibition by integrase inhibitors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16943199     DOI: 10.1074/jbc.M605101200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Dnmt3a-CD is less susceptible to bulky benzo[a]pyrene diol epoxide-derived DNA lesions than prokaryotic DNA methyltransferases.

Authors:  Olga V Lukashevich; Vladimir B Baskunov; Maria V Darii; Alexander Kolbanovskiy; Alexander A Baykov; Elizaveta S Gromova
Journal:  Biochemistry       Date:  2011-01-13       Impact factor: 3.162

2.  Comparison of raltegravir and elvitegravir on HIV-1 integrase catalytic reactions and on a series of drug-resistant integrase mutants.

Authors:  Jessica Marinello; Christophe Marchand; Bryan T Mott; Anjali Bain; Craig J Thomas; Yves Pommier
Journal:  Biochemistry       Date:  2008-08-15       Impact factor: 3.162

3.  Selectivity for strand-transfer over 3'-processing and susceptibility to clinical resistance of HIV-1 integrase inhibitors are driven by key enzyme-DNA interactions in the active site.

Authors:  Mathieu Métifiot; Barry C Johnson; Evgeny Kiselev; Laura Marler; Xue Zhi Zhao; Terrence R Burke; Christophe Marchand; Stephen H Hughes; Yves Pommier
Journal:  Nucleic Acids Res       Date:  2016-07-01       Impact factor: 16.971

4.  The HIV-1 integrase α4-helix involved in LTR-DNA recognition is also a highly antigenic peptide element.

Authors:  Sandy Azzi; Vincent Parissi; Richard G Maroun; Pierre Eid; Olivier Mauffret; Serge Fermandjian
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

5.  HIV-1 Integrase-DNA Recognition Mechanisms.

Authors:  Jacques J Kessl; Christopher J McKee; Jocelyn O Eidahl; Nikolozi Shkriabai; Ari Katz; Mamuka Kvaratskhelia
Journal:  Viruses       Date:  2009-11-05       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.